#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3702	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2268	378.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1660	1660	T	477	T,C,G,A	306,111,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3702	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2268	378.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1394	1394	C	488	C,A,G	445,5,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3702	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2268	378.7	0	HET	.	.	.	C207T,A,G	.	207	207	C	417	417	C	317	C,T,A,G	150,125,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3702	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2268	378.7	0	HET	.	.	.	C451T,A	.	451	451	C	661	661	C	449	C,T,A	202,216,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6476	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4169	369.5	0	.	n	.	0	T695C	SNP	695	695	T	1359	1359	C	489	C,A,T	419,5,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6476	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4169	369.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2635	2635	C	426	C	393	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6476	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4169	369.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2709	2709	A	415	A	380	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6476	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4169	369.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3261	3261	C	460	C,A,G	423,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	396	folP	855	855	100.0	folP.l15.c4.ctg.1	2088	45.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1345	1347	AGC	54;54;55	A;G;C	48;48;49	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	902	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3856	56.1	1	SNP	p	S91F	1	.	.	271	273	TTC	883	885	TTC	59;59;59	T;T;C,A	51;51;55,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	902	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3856	56.1	1	SNP	p	G95N	0	.	.	283	285	GGC	895	897	GGC	61;62;62	G;G;C	57;56;54	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	902	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3856	56.1	1	SNP	p	D95G	1	.	.	283	285	GGC	895	897	GGC	61;62;62	G;G;C	57;56;54	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	410	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1825	55.0	1	SNP	p	G45D	0	.	.	133	135	GGC	778	780	GGC	103;103;103	G;G;C	92;93;94	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	244	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1529	38.1	0	.	n	.	0	A197.	DEL	197	197	A	863	863	A	93	A	87	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3523	54.9	1	SNP	p	D86N	0	.	.	256	258	GAC	956	958	GAC	71;71;74	G;A,C;C	50;43,2;56	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3523	54.9	1	SNP	p	S87R	1	.	.	259	261	CGT	959	961	CGT	75;73;74	C;G,A;T	61;49,1;59	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3523	54.9	1	SNP	p	R87W	0	.	.	259	261	CGT	959	961	CGT	75;73;74	C;G,A;T	61;49,1;59	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3523	54.9	1	SNP	p	R87I	0	.	.	259	261	CGT	959	961	CGT	75;73;74	C;G,A;T	61;49,1;59	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3523	54.9	1	SNP	p	S88P	0	.	.	262	264	TCC	962	964	TCC	74;74;75	T,C;C,A;C	55,1;61,1;66	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	662	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3230	49.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1878	1880	GGC	46;46;46	G;G;C	40;40;40	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.002	penA.34.002	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2696	69.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1616	1618	GCC	116;116;115	G,T;C;C	109,1;110;109	penA.34.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2696	69.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1619	1621	ATG	115;117;117	A;T,G,A;G,T	109;108,1,1;109,1	penA.34.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2696	69.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1631	1633	ACC	116;116;115	A,T,C;C,A;C	106,1,2;108,1;108	penA.34.002:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2696	69.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1631	1633	ACC	116;116;115	A,T,C;C,A;C	106,1,2;108,1;108	penA.34.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2696	69.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2132	2134	ACC	76;76;74	A;C,A;C,A	74;71,1;70,1	penA.34.002:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2696	69.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2186	2188	GCG	77;77;77	G;C,T;G,T,C	67;54,1;66,1,1	penA.34.002:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2696	69.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2186	2188	GCG	77;77;77	G;C,T;G,T,C	67;54,1;66,1,1	penA.34.002:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2696	69.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2309	2311	GGT	64;64;63	G;G,T;T,G	60;57,3;57,1	penA.34.002:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2696	69.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2318	2320	AGC	56;56;56	A,G;G;C,G	38,2;44;37,1	penA.34.002:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	778	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2696	69.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2336	2338	CCG	53;51;51	C;C,G;G,T	46;43,1;45,1	penA.34.002:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1000	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3645	64.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1851	1853	CCG	75;74;73	C,G;C,G;G,C	53,2;63,1;44,7	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	370	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2303	38.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	782	782	C	26	C	20	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	544	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2326	55.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1291	1293	AGA	75;76;76	A;G;A	71;70;72	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	544	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2326	55.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1312	1314	GGT	62;62;62	G;G;T	54;55;54	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	544	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2326	55.7	1	SNP	p	G120K	1	.	.	358	360	AAG	1021	1023	AAG	71;71;73	A;A;G,C,A	66;66;66,1,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	544	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2326	55.7	1	SNP	p	A121N	1	.	.	361	363	AAC	1024	1026	AAC	74;74;73	A,C;A,C;C,A	67,1;65,1;63,4	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	544	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2326	55.7	1	SNP	p	N121D	0	.	.	361	363	AAC	1024	1026	AAC	74;74;73	A,C;A,C;C,A	67,1;65,1;63,4	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2096	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5347	94.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	284	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1646	42.6	1	SNP	p	V57M	1	.	.	169	171	ATG	854	856	ATG	92;91;91	A;T;G	83;86;86	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
